CHS-0214

In latest setback, another Coherus partner bails out on Amgen biosimilar deal
Endpoints
Wed, 07/5/17 - 09:37 am
Coherus
Amgen
biosimilars
Daiichi Sankyo
CHS-0214
rheumatoid arthritis
Enbrel
Baxalta, Coherus say Enbrel biosimilar succeeds in study
Yahoo/Reuters
Mon, 01/11/16 - 08:36 am
Baxalta
Coherus Biosciences
biosimilars
Enbrel
rheumatoid arthritis
CHS-0214